Learn About Acute Myeloblastic Leukemia without Maturation

View Main Condition: Leukemia

What is the definition of Acute Myeloblastic Leukemia without Maturation?
A rare, acute myeloid leukemia characterized by no significant myeloid maturation and more than 90% blast cells in the non-erythroid population. Various degrees of anemia, thrombocytopenia, or pancytopenia are present. Frequent clinical manifestations include fatigue, fever, bleeding disorders, and organomegaly, especially hepatosplenomegaly.
Save information for later
Sign Up
What are the alternative names for Acute Myeloblastic Leukemia without Maturation?
  • Acute myeloblastic leukemia without maturation
  • AML M1
  • Acute myeloblastic leukemia M1
  • Acute myeloblastic leukemia type 1
Who are the top Acute Myeloblastic Leukemia without Maturation Local Doctors?
Elite
Elite
 
 
 
 
Learn about our expert tiers
Learn more
Elite
What are the latest Acute Myeloblastic Leukemia without Maturation Clinical Trials?
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients With Hematologic Malignancies and Other Indications

Summary: This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase Ib/II Open Label Dose Confirmation, Proof of Concept Study of Siremadlin in Combination With Venetoclax Plus Azacitidine in Unfit Adult AML Participants Who Responded Sub-optimally to First-line Venetoclax Plus Azacitidine Treatment and in Participants With Newly Diagnosed Unfit AML Presenting With High-risk Clinical Features

Summary: A study of siremadlin in combination with venetoclax plus azacitidine in adult participants with AML who are ineligible for chemotherapy.

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

What are the Latest Advances for Acute Myeloblastic Leukemia without Maturation?
Current status and future perspective of CAR T-cell therapy for acute myeloid leukemia.
Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia: An Overview of Systematic Reviews.
Tired of the same old research?
Check Latest Advances
AML-055 Outcomes Based on Sequential Use of Venetoclax Based Therapy and Targeted Therapy in Acute Myeloid Leukemia (AML).